A Phase 2, Randomized, Double-blind, Placebo-controlled, Study to Evaluate Multiple Doses of AK001 in Patients With Moderate to Severe Nasal Polyposis
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 04 Aug 2017
At a glance
- Drugs AK 001 (Primary)
- Indications Nasal polyps
- Focus Therapeutic Use
- Sponsors Allakos
- 03 Aug 2017 This study has been suspended in Netherlands as per European Clinical Trials Database.
- 31 Jul 2017 Planned End Date changed from 1 Jul 2017 to 1 Jan 2018.
- 31 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jan 2018.